These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 2934477

  • 1. The immunosuppressive activity of L-leucyl-L-leucine methyl ester: selective ablation of cytotoxic lymphocytes and monocytes.
    Thiele DL, Lipsky PE.
    J Immunol; 1986 Feb 01; 136(3):1038-48. PubMed ID: 2934477
    [Abstract] [Full Text] [Related]

  • 2. Modulation of human natural killer cell function by L-leucine methyl ester: monocyte-dependent depletion from human peripheral blood mononuclear cells.
    Thiele DL, Lipsky PE.
    J Immunol; 1985 Feb 01; 134(2):786-93. PubMed ID: 3965574
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Phenotype of the accessory cell necessary for mitogen-stimulated T and B cell responses in human peripheral blood: delineation by its sensitivity to the lysosomotropic agent, L-leucine methyl ester.
    Thiele DL, Kurosaka M, Lipsky PE.
    J Immunol; 1983 Nov 01; 131(5):2282-90. PubMed ID: 6605384
    [Abstract] [Full Text] [Related]

  • 6. Human peripheral blood gamma delta T cells are uniformly sensitive to destruction by the lysosomotropic agents leucine methyl ester and leucyl leucine methyl ester.
    Pechhold K, Kabelitz D.
    Eur J Immunol; 1993 Feb 01; 23(2):562-5. PubMed ID: 8436187
    [Abstract] [Full Text] [Related]

  • 7. Apoptosis is induced in cells with cytolytic potential by L-leucyl-L-leucine methyl ester.
    Thiele DL, Lipsky PE.
    J Immunol; 1992 Jun 15; 148(12):3950-7. PubMed ID: 1602138
    [Abstract] [Full Text] [Related]

  • 8. Lethal graft-vs-host disease induced by a class II MHC antigen only disparity is not mediated by cytotoxic T cells.
    Thiele DL, Bryde SE, Lipsky PE.
    J Immunol; 1988 Nov 15; 141(10):3377-82. PubMed ID: 3053897
    [Abstract] [Full Text] [Related]

  • 9. Depletion of NK cells with the lysosomotropic agent L-leucine methyl ester and the in vitro generation of NK activity from NK precursor cells.
    Shau H, Golub SH.
    J Immunol; 1985 Feb 15; 134(2):1136-41. PubMed ID: 3871208
    [Abstract] [Full Text] [Related]

  • 10. Generalized toxicity of L-leucyl-leucine-methyl ester for lymphocyte functions.
    Mowat AM, Leck PA.
    Immunology; 1990 Apr 15; 69(4):564-9. PubMed ID: 2335375
    [Abstract] [Full Text] [Related]

  • 11. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
    Burns GF, Triglia T, Werkmeister JA.
    J Immunol; 1984 Sep 15; 133(3):1656-63. PubMed ID: 6611374
    [Abstract] [Full Text] [Related]

  • 12. Depletion of human NK cells with monoclonal antibodies allows the generation of cytotoxic T lymphocytes without NK-like cells in mixed cultures.
    Strassmann G, Bach FH, Zarling JM.
    J Immunol; 1983 Apr 15; 130(4):1556-60. PubMed ID: 6220056
    [Abstract] [Full Text] [Related]

  • 13. Regulation of cellular function by products of lysosomal enzyme activity: elimination of human natural killer cells by a dipeptide methyl ester generated from L-leucine methyl ester by monocytes or polymorphonuclear leukocytes.
    Thiele DL, Lipsky PE.
    Proc Natl Acad Sci U S A; 1985 Apr 15; 82(8):2468-72. PubMed ID: 3857595
    [Abstract] [Full Text] [Related]

  • 14. Antigenic, functional, and molecular genetic studies of human natural killer cells and cytotoxic T lymphocytes not restricted by the major histocompatibility complex.
    Lanier LL, Le AM, Cwirla S, Federspiel N, Phillips JH.
    Fed Proc; 1986 Nov 15; 45(12):2823-8. PubMed ID: 3095151
    [Abstract] [Full Text] [Related]

  • 15. Fucose-activated killer (FAK) cells: anomalous killers with augmented cytotoxic activity.
    Stanková J, Rola-Pleszczynski M.
    J Immunol; 1985 Dec 15; 135(6):3719-28. PubMed ID: 2415584
    [Abstract] [Full Text] [Related]

  • 16. Leucyl-leucine methyl ester treatment of donor cells permits establishment of immunocompetent parent----F1 chimeras that are selectively tolerant of host alloantigens.
    Thiele DL, Calomeni JA, Lipsky PE.
    J Immunol; 1987 Oct 01; 139(7):2137-42. PubMed ID: 3309052
    [Abstract] [Full Text] [Related]

  • 17. The effect of leucyl-leucine methyl ester on proliferation and Ig secretion of EBV-transformed human B lymphocytes.
    Ohlin M, Danielsson L, Carlsson R, Borrebaeck CA.
    Immunology; 1989 Apr 01; 66(4):485-90. PubMed ID: 2541070
    [Abstract] [Full Text] [Related]

  • 18. Hydrocortisone suppresses the generation of nonspecific "anomalous" killers but not specific cytolytic T lymphocytes in human mixed lymphocyte-tumor cultures.
    Muul LM, Gately MK.
    J Immunol; 1984 Mar 01; 132(3):1202-7. PubMed ID: 6198383
    [Abstract] [Full Text] [Related]

  • 19. The action of leucyl-leucine methyl ester on cytotoxic lymphocytes requires uptake by a novel dipeptide-specific facilitated transport system and dipeptidyl peptidase I-mediated conversion to membranolytic products.
    Thiele DL, Lipsky PE.
    J Exp Med; 1990 Jul 01; 172(1):183-94. PubMed ID: 1972727
    [Abstract] [Full Text] [Related]

  • 20. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes.
    Lanier LL, Le AM, Civin CI, Loken MR, Phillips JH.
    J Immunol; 1986 Jun 15; 136(12):4480-6. PubMed ID: 3086432
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.